Article

10 Questions About Gout: A Quiz

Should urate-lowering therapy be continued during an acute gout attack? Which antihypertensive has mild uricosuric effects? Test yourself with these questions and more.

Gout, the "disease of kings," is the most common cause of inflammatory arthritis throughout the world. In recent decades, the prevalence has nearly doubled.1

Updated guidelines on gout management from the British Society for Rheumatology/British Health Professionals in Rheumatology focus on patient education. Try this 10-question quiz to test your own knowledge.

 

1. Which of the following is NOT a first-line option for the pharmacologic treatment of acute gout?

A. NSAIDs

B. Corticosteroids

C. Oral colchicine

D. Aspirin

Please click below for answer and next question.

The correct answer is D. Aspirin.
*********************************

2. How long after the onset of an acute gout attack should pharmacologic therapy be initiated?

A. Within 1 hour

B. Within 24 hours

C. After 24 hours

D. After 48 hours

Please click below for answer and next question.

The correct answer is B. Within 24 hours.
*********************************

3. True or false? Ice packs can be effective adjuncts to the management of an acute gout attack.

A. True

B. False

Please click below for answer and next question.

The correct answer is A. True.
*********************************

4. The initial goal of urate-lowering therapy is to reduce and maintain the serum uric acid at or below what recommended level to prevent further crystal formation and to dissolve existing crystals?

A. 100 µmol/L

B. 200 µmol/L

C. 300 µmol/L

D. 400 µmol/L

Please click below for answer and next question.

The correct answer is C. 300 µmol/L.
*********************************

5. Which of the following is the recommended first-line urate-lowering therapy to consider?

A. Febuxostat

B. Allopurinol

C. Probenecid

D. Benzbromarone

Please click below for answer and next question.

The correct answer is B. Allopurinol.
*********************************

6. True or false? Established pharmacologic urate-lowering therapy should be continued, without interruption, during an acute attack of gout.

A. True

B. False

Please click below for answer and next question.

The correct answer is A. True.
*********************************

7. Which antihypertensive has been shown to have mild uricosuric effects in patients with gout?

A. Lisinopril

B. Amlodipine

C. Propranolol

D. Losartan

Please click below for answer and next question.

The correct answer is D. Losartan.
*********************************

8. True or false? Consumption of fructose- or sugar-sweetened soft drinks is an established risk factor for the development of gout.

A. True

B. False

Please click below for answer and next question.

The correct answer is A. True.
*********************************

9. Consumption of which of the following fruits was associated with a statistically significant 35% lower risk of gout attacks?

A. Apple

B. Peach

C. Cherry

D. Banana

Please click below for answer and next question.

The correct answer is C. Cherry.
*********************************

10. True or false? Vitamin C supplements have a weak uric acid-lowering effect.

A. True

B. False

Please click below for answer.

The correct answer is A. True.
*********************************

For a summary of the highlights of the British Society for Rheumatology/British Health Professionals in Rheumatology guideline, please see Revised Gout Guideline Eyes Education.

References:

1. Hui M, Carr A, Cameron C, et al. The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology. 2017;56:e1-e20. doi.org/10.1093/rheumatology/kex156.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.